Form 4: Imunon Director Donald P. Braun Acquires 25,000 Shares of Common Stock

Director Donald P. Braun purchased 25,000 shares of Imunon, Inc. (IMNN) common stock on August 20, 2024, at a price of $1.1792 per share.

Summary

• On August 20, 2024, Donald P. Braun, a director of Imunon, Inc., acquired 25,000 shares of the company's common stock.
• The shares were purchased on the open market at a price of $1.1792 per share.
• Following the transaction, Braun directly owns 25,597 shares of Imunon common stock.
• The filing also includes a power of attorney, effective January 27, 2025, granting Susan Eylward the authority to act on Braun's behalf for SEC filings related to Imunon securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. Insider buying is generally a good sign, but the impact is limited without additional context or larger transactions.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are routine disclosures required by the SEC when insiders (officers, directors, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings provide transparency to the market and allow investors to track insider activity, which can sometimes be an indicator of a company's prospects.

Comparison to Industry Standards

• Insider buying is generally viewed positively, but the significance depends on the size of the purchase relative to the insider's existing holdings and the company's market capitalization.
• Compared to similar transactions in other small-cap biotech companies, this purchase is a moderate-sized transaction by a director.

Stakeholder Impact

• The purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Imunon, Director, Stock Purchase, Donald P. Braun, IMNN, Beneficial Ownership, SEC Filing